glp-1 index fund The Obesity Drug Boom The Obesity Drug Boom

On March 20, 2026, Chinas patent on semaglutide (the active ingredient in Ozempic and Wegovy) expiresyears ahead of patent expirations in the U.

![Figure][1] Graphical Abstract: ### Competing Interest Statement The FR + FMG laboratory receives funding from AstraZeneca, Eli Lilly and LGM for unrelated research and FMG consults for Kallyope (New York)

Explore UK clinical evidence, who may benefit, and key safety considerations.

At Genesis Lifestyle Medicine, we ensure you achieve your goals safely and effectively

And when people tell me they feel stuck with their weight, I always say the same thing:It s never too late to take your health back.

Lewis O